CORC  > 复旦大学上海医学院
Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study
Huang, Zhi-Liang; Cao, Xun; Luo, Ruo-Zhen; Chen, You-Fang; Zhu, Lin-Chun; Wen, Zhesheng
刊名ONCOLOGY LETTERS
2016
卷号11期号:1
关键词non-small cell lung cancer breast cancer 1 excision repair cross-complementation group 1 ribonucleotide reductase M1 class III beta-tubulin
ISSN号1792-1074
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4642112
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Huang, Zhi-Liang,Cao, Xun,Luo, Ruo-Zhen,et al. Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study[J]. ONCOLOGY LETTERS,2016,11(1).
APA Huang, Zhi-Liang,Cao, Xun,Luo, Ruo-Zhen,Chen, You-Fang,Zhu, Lin-Chun,&Wen, Zhesheng.(2016).Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study.ONCOLOGY LETTERS,11(1).
MLA Huang, Zhi-Liang,et al."Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study".ONCOLOGY LETTERS 11.1(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace